The Efficiency of MRI Technique In Determining The Depth of Myometrial Invasion In Endometrial Cancer

The aim of the present study was to determine the efficiency of preoperative magnetic resonance imaging investigation in the determination of the depth of myometrial invasion in endometrial cancer. 41 cases diagnosed with endometrial cancer via endometrial sampling and who underwent investigation with magnetic resonance imaging in preoperative period so as to determine the depth of myometrial invasion were evaluated retrospectively. Imaging and operation data and pathology results were re trieved from hospital files. Mean age of the patients was 60.5±10.18 (43-86). As surgical procedure, they underwent total abdominal hysterectomy and bilateral salpingoophorectomy, bilateral pelvic lymph node dissection ± paraaortic lymph node dissection. Preoperative magnetic resonance imaging findings were compared with postoperative histology results and sensitivity of magnetic resonance imaging was found to be 68.2%, specificity 84.5%, PPD 68.2% and NPD 84.5% in the evaluation of the depth of myometrial invasion. Magnetic resonance imaging is an efficient imaging method in the preoperative evaluation of the depth of myometrial invasion in endometrial cancer

___

1. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. "SEER cancer statistics review." National Cancer Institute 2008.

2. Gultekin, M, et al. Trends of Gynecological Cancers in Turkey: Toward Europe or Asia? Int J Gynecol Cancer 2017; 27: S1-S9.

3. Jemal, Ahmedin, et al. "Global cancer statistics." CA: a cancer journal for clinicians 2011; 61.2: 69-90.

4. Gallup DG, Stock RJ. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol 1984; 64: 417-420.

5. Carneiro MM, Lamaita RM, Ferreira MC, et al. Fertility preservation in endometrial cancer: is it safe? Review of the literature JBRA Assist Reprod V 20 no 4 2016.

6. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005; 366: 491-505.

7. Cicchillitti L, Corrado G, Carosi M, et al. Lamin A as novel molecular prognostic biomarker for EC. It J Gynaecol Obstet 2016; 28: N. 2.

8. Bogani G, Dowdy SC, Cliby WA, et al Management of endometrial cancer: issues and controversies. Eur J Gynaecol Oncol 2016; 37: 6- 12.

9. Caponio MA, Addati T, Popescu O, et al. P16INK4a protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: Diagnostic and clinical consideration. CancerBiomarkers 2014; 14: 169175.

10. American College of Obstetricians and Gynocologists: Tamoxsifen and uterin cancer. Committee Opinion 2006; 1475-1478.

11. Feldman, S. A. R. A. H., ROSS S. Berkowitz, and A. N. Tosteson. "Cost-effectiveness of strategies to evaluate postmenopausal bleeding." Obstetrics and gynecology 1993; 968-975.

12. Gordon, S. J., and J. Westgate. "The incidence and management of failed Pipelle sampling in a general outpatient clinic." Australian and New Zealand journal of obstetrics and gynaecology 1999; 115-118.

13. Mac Kenzie I, Bibby J. Critical assessment of dilatation and curettage in 1029 women. Lancet 1978; 566-568.

14. Obermair, Andreas, et al. "Does hysteroscopy facilitate tumor cell dissemination? Incidence of peritoneal cytology from patients with early stage endometrial carcinoma following dilatation and curettage (D & C) versus hysteroscopy and D & C." Cancer 2000; 139-143.

15. Cicinelli, Ettore, et al. "Risk of long-term pelvic recurrences after fluid minihysteroscopy in women with endometrial carcinoma: a controlled randomized study." Menopause 2010;17: 511-515.

16. Mutch, David G. "The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas." Gynecologic oncology 2009; 115: 325- 328.

17. Patel S, Liyanage SH, Sadhev A, et al. Imaging of endometrial and cervical cancer. Insights Imaging 2010; 1: 309-328.

18. Gull B, Karlsson B, Milsom I, Wikland M, Granberg S. Transvaginal sonography of the endometrium in a representative sample of postmenopausal women. Ultrasound Obstet Gynecol 1996; 7: 322-327.

19. Smith-Bindman R, Kerlikowske K, Feldstein VA, et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 1998; 280: 1510-1517.

20. Hardesty LA, Sumkin JH, Hakim C, Johns C, Nath M. The ability of helical CT to preoperatively stage endometrial carcinoma. AJR Am J Roentgenol 2001; 176: 603-606.

21. Cetinkaya K, Atalay F, Bacinoglu A. Risk factors of lymph node metastases with endometrial carcinoma Asian Pas J Can Prev 2014; 15: 6353- 6356.

22. Murakami T, Kurachi H, Nakamura H, et al. Cervical invasion of endometrial carcinomaevaluation by parasagittal MR imaging. Acta Radiol 1995; 36: 248-253.

23. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 2009; 105: 109.

24. Silverberg SG, Kurman RJ, Nogales F, Mutter GL, Kubik-Huch RA, Tavassoli FA. Epithelial tumours and related lesions. In: Tavassoli FA, Devilee P, eds. World Health Organization classifi cation of tumours: pathology and geneticstumours of the breast and female genital organs. Lyon: IARC Press 2003; 217-232.

25. Sorosky JI. Endometrial cancer. Obstet Gynecol 2012; 120: 383-397.

26. Rizzo S, Femia M, Buscarino V. et al. Endometrial cancer: an overview of novelties in treatment and related imaging keypoints for local staging. Cancer Imaging 2018; 18: 45.

27. Thickman D, Kressel H, Gussman D, Axel L, Hogan M. Nuclear magnetic resonance imaging in gynecology. American journal of obstetrics and gynecology 1984; 149: 835-840.

28. Euscher E, Fox P, Bassett R, et al. The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma. Am J Surg Pathol 2013; 37: 1728-1736.

29. Berretta R, Merisio C, Piantelli G, Rolla M, Giordano G, Melpignano M, Nardelli GB. Preoperative transvaginal ultrasonography and intraoperative gross examination for assessing myometrial invasion by endometrial cancer. J Ultrasound Med 2008; 27: 349-355.

30. Varpula MJ, Klemi PJ. Staging of uterine endometrial carcinoma with ultra-low field (0, 02 T) MRI: acomparative study with CT. J Comput Assist Tomogr 1993; 17: 641-647.

31. DiSaia PJ, Creasman WT, Boronow RC., Blessing JA,: Risk factors and recurrent patterns in steage I endometrial cancer. Am J Obsest Gynecol 1985; 151: 1009-1015.

32. Hricak H, Rubinstein LV, Gherman GM, Karstaedt N.: MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study. Radiology 1991; 179: 829- 832.

33. Worthington JL, Balfe DM, Lea JKT, at al. Uterine neoplasms: MR imaging. Radiology 1986; 159: 725-730.

34. Mcevoy, Sinead H., et al. Fertility-sparing for young patients with gynecologic cancer: how MRI can guide patient selection prior to conservative management. Abdominal Radiology 2017; 10: 2488-2512.

35. Yamashita Y, Mizutani H, Torashima M, Takahashi M, Miyazaki K, Okamura H, et al.: Assessment of Myometrial Invasion by Endometrial Carcinoma: transvaginal Sonography vs Contrast-enhanced MR Imaging, AJR Am J Roentgenol 1993; 161: 595-599.

36. Lien HH et al. Cancer of the endometrium: Value of the MR imaging in determining depth of invasion into the myometrium, AJR Am J Roentgenol 1991; 157: 1221-1223.

37. Body, Noemie, et al. "Are preoperative histology and MRI useful for classification of endometrial cancer risk?." BMC cancer 2016; 1: 498.

38. Tanaka, Tomohito, et al. "Preoperative MRI and intraoperative frozen section diagnosis of myometrial invasion in patients with endometrial cancer." International Journal of Gynecologic Cancer 2015; 5: 879-883.

39. Atalay, Funda, and Kadir Çetinkaya. "Endometrium Kanserli Hastalarda Miyometrial İnvazyon: Ameliyat Öncesi Magnetik Rezonans Görüntüleme İnvazyonu Tahmin Edebilir Mi?." Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 2016; 13.2.

40. Du, Lixin, et al. "The diagnostic value of multimodality MRI in endometrial carcinoma staging." Acta Radiologica 2017; 58: 609-616.

41. Peungjesada S, Bhosale PR, Balachandran A, Iyer RB. Magnetic resonance imaging of endometrial carcinoma. J Comput Assist Tomogr 2009; 33: 601-608
Eastern Journal of Medicine-Cover
  • ISSN: 1301-0883
  • Başlangıç: 1996
  • Yayıncı: ERBİL KARAMAN
Sayıdaki Diğer Makaleler

Traditional and Complementary Medicine Methods Which Have Become Widespread from The Perspective of Family Physicians and self-Employed Pharmacists; Approaches, Thoughts

NAGİHAN YILDIZ ÇELTEK, UFUK ÜNLÜ

Evaluation of Psychological Variables in Women Who Takes Infertility Care

Faruk KURUHAN, Ümit Sertaç ÇÖPOĞLU

Does Suppression of Tsh Affect The Mean Platelet Volume? Retrospective Case Control Study

MINE OZTÜRK

Retrospective Evaluation of Percutaneous Tracheostomy Methods Applied In A Tertiary Intensive Care Unit

Cevdet YARDIMCI, Gamze TALİH, Ahmet YÜKSEK

The Effect of Positive Pressure Volume Control Mechanical Ventilation On Arterial Stiffness Measured By Carotid-Femoral (Aortic) Pulse Wave Velocity In Patients Who Operated For Coronary Artery Bypass Surgery

Pınar KOLUSARI, Kamil KARAOĞLU

Effects of Parenteral Glutamine Supplementation on Endocan Levels in Septic Patients

Basak KİLİC, HÜLYA ÇİÇEK, Ayse Ozlem METE, Suleyman GANİDAGLİ, Berna Kaya UĞUR

Low superoxide dismutase and catalase is associated malondialdehyde and ischemia modified albumin in patients with Non-ST elevated myocardial infarction (NSTEMI)

Nesim ALADAĞ, Abdulcebbar ŞİPAL

Real-Time Detection of Doxorubicin-Induced Apoptosis in Breast Cancer Cells Using the Back Reflection Spectroscopy

Ertan KUCUKSAYAN, Aslinur SİRCAN-KUCUKSAYAN

Relationship Between Ocular Pseudoexfoliation and Sensorineural Hearing Loss

Serek TEKİN, MUHAMMED BATUR, Ufuk DÜZENLİ, ERBİL SEVEN, MUHAMMET DERDA ÖZER

The Types of Urodynamic Detrusor Overactivity and its Relationship With Neurological Diseases. 10-years Follow-up of 1000 Invasive Urodynamic Studies

Alkan ÇUBUK, Ahmet SAHAN, Orkunt ÖZKAPTAN, Berkan ŞİMŞEK, Muhammed SULUKAYA, Fatih TARHAN